Patient diversity and representation in clinical trials have become a priority for stakeholders across the industry and for regulatory authorities around the world. There are many challenges in the recruitment and retention of under-represented populations in clinical trials. How can the research community address the root causes for the lack of diversity, even at the study design concept stage?
With the right strategy, an ongoing commitment to ensuring representation and a collaborative effort between the sponsor, the CRO and investigative sites, representative diversity in trial populations can be achieved. The key to achieving diversity in clinical trial participation is to understand the drivers of diversity in the design of your trial.
Join the featured speakers as they discuss some of the factors underpinning the lack of patient diversity in clinical trials, investigate the implications this has for patients and discuss what we can do to design more patient-centric and diverse clinical trials.
